ArticleJournal of surgical case reports2025
A case of hepatic sarcomatoid cholangiocarcinoma with diaphragmatic and right lower lobe lung invasion.
Article in Journal of surgical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- ICMT deficiency ameliorates weight loss and mortality, but not tumor formation in a mouse model of liver cancer.Cell communication and signaling : CCS · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hepatic sarcomatoid cholangiocarcinoma is a rare, accounting for <1% of cases and aggressive malignant neoplasm. This report presents a case of a 35-year-old female patient who presented with right shoulder pain, general weakness, anorexia, and weight loss. Imaging studies revealed a hepatic mass in segment S8, with invasion into the diaphragm and right lower lobe of the lung. The patient underwent surgical resection, and the pathological diagnosis confirmed hepatic sarcomatoid cholangiocarcinoma. This case report discusses the clinical presentation, diagnosis, and treatment of this rare malignancy, emphasizing the importance of early diagnosis and aggressive management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.